CN101481383B - 头孢地尼酸式复盐化合物及制备方法 - Google Patents
头孢地尼酸式复盐化合物及制备方法 Download PDFInfo
- Publication number
- CN101481383B CN101481383B CN2008101642113A CN200810164211A CN101481383B CN 101481383 B CN101481383 B CN 101481383B CN 2008101642113 A CN2008101642113 A CN 2008101642113A CN 200810164211 A CN200810164211 A CN 200810164211A CN 101481383 B CN101481383 B CN 101481383B
- Authority
- CN
- China
- Prior art keywords
- cefdinir
- drip
- acid
- stirring
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Abstract
Description
序号 | 新化合物 | 溶解度 |
1 | 头孢地尼硫酸1.5氢0.5钠 | 溶解 |
2 | 头孢地尼硫酸1.5氢0.5钾 | 溶解 |
3 | 头孢地尼硫酸1.5氢0.5铵 | 溶解 |
4 | 头孢地尼硫酸氢钠 | 微溶 |
5 | 头孢地尼硫酸氢钾 | 微溶 |
6 | 头孢地尼硫酸氢铵 | 微溶 |
7 | 头孢地尼磷酸二氢钠 | 微溶 |
8 | 头孢地尼磷酸二氢钾 | 微溶 |
9 | 头孢地尼磷酸二氢铵 | 微溶 |
药物 | Cmax(μg/ml) | 达峰时间(h) | AUC(0-10)(μg·h/ml) | 生物利用度提高百分数 |
上市品胶囊 | 21.80 | 3 | 102.11 | / |
头孢地尼硫酸氢钠 | 65.43 | 3 | 255.27 | 149% |
头孢地尼硫酸1.5氢0.5钠 | 50.23 | 3 | 239.96 | 135% |
头孢地尼硫酸氢钾 | 54.13 | 2.5 | 261.41 | 156% |
头孢地尼硫酸1.5氢0.5钾 | 47.65 | 3 | 213.40 | 109% |
头孢地尼硫酸氢铵 | 43.63 | 3 | 202.18 | 98% |
头孢地尼硫酸1.5氢0.5铵 | 34.12 | 2.5 | 160.31 | 57% |
头孢地尼磷酸二氢钠 | 27.28 | 2.5 | 123.55 | 20% |
头孢地尼磷酸二氢钾 | 30.37 | 3 | 152.15 | 49% |
Claims (2)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101642113A CN101481383B (zh) | 2008-12-31 | 2008-12-31 | 头孢地尼酸式复盐化合物及制备方法 |
RU2011133302/04A RU2531276C2 (ru) | 2008-12-31 | 2009-12-29 | Цефдинира кислая соль и способ ее получения |
KR1020117017402A KR101577488B1 (ko) | 2008-12-31 | 2009-12-29 | 세프디니르 산성 복염 화합물 및 제조방법 |
MX2011007006A MX2011007006A (es) | 2008-12-31 | 2009-12-29 | Sal doble de acido de cefdinir y su preparacion. |
JP2011542657A JP5771152B2 (ja) | 2008-12-31 | 2009-12-29 | セフジニル酸式複塩化合物を含む経口投与製剤およびその調製方法 |
PCT/CN2009/076164 WO2010075765A1 (zh) | 2008-12-31 | 2009-12-29 | 头孢地尼酸式复盐化合物及制备方法 |
EP09836052.2A EP2385054B1 (en) | 2008-12-31 | 2009-12-29 | Cefdinir acid double salt and its preparation |
US13/172,907 US8329895B2 (en) | 2008-12-31 | 2011-06-30 | Cefdinir acid double salt and method for producing the same |
ZA2011/05542A ZA201105542B (en) | 2008-12-31 | 2011-07-28 | Cefdinir acid double salt and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101642113A CN101481383B (zh) | 2008-12-31 | 2008-12-31 | 头孢地尼酸式复盐化合物及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101481383A CN101481383A (zh) | 2009-07-15 |
CN101481383B true CN101481383B (zh) | 2012-01-11 |
Family
ID=40878693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101642113A Active CN101481383B (zh) | 2008-12-31 | 2008-12-31 | 头孢地尼酸式复盐化合物及制备方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US8329895B2 (zh) |
EP (1) | EP2385054B1 (zh) |
JP (1) | JP5771152B2 (zh) |
KR (1) | KR101577488B1 (zh) |
CN (1) | CN101481383B (zh) |
MX (1) | MX2011007006A (zh) |
RU (1) | RU2531276C2 (zh) |
WO (1) | WO2010075765A1 (zh) |
ZA (1) | ZA201105542B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101481383B (zh) * | 2008-12-31 | 2012-01-11 | 杭州奥默医药技术有限公司 | 头孢地尼酸式复盐化合物及制备方法 |
CN101862307A (zh) * | 2010-03-19 | 2010-10-20 | 杭州奥默医药技术有限公司 | 硫酸氢头孢地尼钠胶囊及其制备方法 |
CN101870698B (zh) * | 2010-04-02 | 2012-10-17 | 漆又毛 | 磺酰苯基咪唑并三嗪衍生物及制备方法 |
CN101870699B (zh) * | 2010-04-06 | 2013-11-20 | 漆又毛 | 苯磺酰基哌嗪衍生物 |
CN101863891A (zh) * | 2010-06-11 | 2010-10-20 | 漆又毛 | 三氟甲基四氢三唑并吡嗪衍生物及制备方法 |
CN102336644A (zh) * | 2011-07-26 | 2012-02-01 | 华中科技大学 | 烷基取代乙酸盐及其在有机电致发光器件中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4559334A (en) * | 1983-08-26 | 1985-12-17 | Fujisawa Pharmaceutical Co., Ltd. | 7-Substituted-3-vinyl-3-cephem compounds and processes for production of the same |
CN1415615A (zh) * | 2002-10-24 | 2003-05-07 | 王登之 | 新的化合物头孢地尼钠 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK162718C (da) * | 1982-09-30 | 1992-05-11 | Fujisawa Pharmaceutical Co | Analogifremgangsmaade til fremstilling af 7-substitueret-3-vinyl-3-cephemforbindelser |
ZA885709B (en) * | 1987-08-19 | 1989-04-26 | Fujisawa Pharmaceutical Co | Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid(syn isomer) |
ES2175167T3 (es) * | 1995-12-27 | 2002-11-16 | Hanmi Pharmaceutical Co Ltd | Procedimiento para la preparacion de cefdinir. |
AT405283B (de) | 1997-04-04 | 1999-06-25 | Biochemie Gmbh | Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung |
KR100451672B1 (ko) * | 2001-06-05 | 2004-10-08 | 한미약품 주식회사 | 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법 |
ITMI20022076A1 (it) * | 2002-10-01 | 2004-04-02 | Antibioticos Spa | Sali di intermedi del cefdinir. |
US20090036672A1 (en) * | 2002-10-01 | 2009-02-05 | Antibioticos S.P.A. | Intermediate cefdinir salts |
ITMI20022724A1 (it) * | 2002-12-20 | 2004-06-21 | Antibioticos Spa | Sali cristallini del cefdinir. |
ITMI20042231A1 (it) * | 2004-11-19 | 2005-02-19 | Antibioticos Spa | Cefdinir sale d'ammonio in forma cristallina |
WO2007053724A2 (en) * | 2005-10-31 | 2007-05-10 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of cefdinir potassium salt |
JP2008526782A (ja) * | 2005-10-31 | 2008-07-24 | テバ ファーマシューティカル インダストリーズ リミティド | セフジニルセシウム塩結晶 |
CN101481383B (zh) * | 2008-12-31 | 2012-01-11 | 杭州奥默医药技术有限公司 | 头孢地尼酸式复盐化合物及制备方法 |
-
2008
- 2008-12-31 CN CN2008101642113A patent/CN101481383B/zh active Active
-
2009
- 2009-12-29 MX MX2011007006A patent/MX2011007006A/es active IP Right Grant
- 2009-12-29 WO PCT/CN2009/076164 patent/WO2010075765A1/zh active Application Filing
- 2009-12-29 RU RU2011133302/04A patent/RU2531276C2/ru not_active IP Right Cessation
- 2009-12-29 KR KR1020117017402A patent/KR101577488B1/ko active IP Right Grant
- 2009-12-29 JP JP2011542657A patent/JP5771152B2/ja not_active Expired - Fee Related
- 2009-12-29 EP EP09836052.2A patent/EP2385054B1/en not_active Not-in-force
-
2011
- 2011-06-30 US US13/172,907 patent/US8329895B2/en active Active
- 2011-07-28 ZA ZA2011/05542A patent/ZA201105542B/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4559334A (en) * | 1983-08-26 | 1985-12-17 | Fujisawa Pharmaceutical Co., Ltd. | 7-Substituted-3-vinyl-3-cephem compounds and processes for production of the same |
CN1415615A (zh) * | 2002-10-24 | 2003-05-07 | 王登之 | 新的化合物头孢地尼钠 |
Also Published As
Publication number | Publication date |
---|---|
CN101481383A (zh) | 2009-07-15 |
EP2385054B1 (en) | 2013-10-02 |
JP5771152B2 (ja) | 2015-08-26 |
WO2010075765A9 (zh) | 2010-09-10 |
US8329895B2 (en) | 2012-12-11 |
KR101577488B1 (ko) | 2015-12-14 |
JP2012513957A (ja) | 2012-06-21 |
RU2011133302A (ru) | 2013-02-20 |
ZA201105542B (en) | 2012-05-25 |
EP2385054A4 (en) | 2011-12-21 |
EP2385054A1 (en) | 2011-11-09 |
RU2531276C2 (ru) | 2014-10-20 |
US20110257388A1 (en) | 2011-10-20 |
MX2011007006A (es) | 2011-09-15 |
KR20110110226A (ko) | 2011-10-06 |
WO2010075765A1 (zh) | 2010-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101481383B (zh) | 头孢地尼酸式复盐化合物及制备方法 | |
CN102432629B (zh) | 一种头孢曲松钠粗品的精制方法 | |
CN103102357B (zh) | 一种头孢呋辛钠的合成方法 | |
CN107163166B (zh) | 一种壳聚糖-柠檬酸-稀土配合物的制备方法 | |
JP2012513957A5 (zh) | ||
CN110393720B9 (zh) | 曲索芬头孢曲松钠化合物药物制剂及治疗免疫机能低下患者感染的新适应症 | |
PL109311B1 (en) | Method of producing stabilized sodium salt of 7-/d-2-formyloxy-2-phenyloacetamido/-3-/methylo-1h-tetrazolylo-5-thiomethylo/-3-cephemocarboxylic-4 acid | |
CN100486978C (zh) | 替卡西林二钠盐的制备方法 | |
CN103193799A (zh) | 一种硫酸头孢喹肟的化学合成方法 | |
CN109232610A (zh) | 一种头孢尼西二苄基乙二胺盐的精制方法 | |
CN102101858A (zh) | 雷莫司琼衍生物及其制备方法和用途 | |
CN101418015B (zh) | 头孢曲松磷酰化衍生物 | |
CN103709219A (zh) | 一种泰乐菌素的提取方法 | |
CN101591347A (zh) | 头孢克肟酸式复盐化合物及其制备方法 | |
CN105997931A (zh) | 一种头孢克肟胶囊及其制备方法 | |
CN101108858A (zh) | 一种制备硫酸头孢喹诺的方法 | |
US3900458A (en) | Mixed salts of polsulfuric esters of naturally occurring glycopeptides with metals and organic bases, and process for producing same | |
CN102993216A (zh) | 盐酸头孢噻呋的一种制备方法 | |
CN110894207B (zh) | 一种盐酸克林霉素棕榈酸酯的纯化方法 | |
JPH0535149B2 (zh) | ||
CN111560028A (zh) | 盐酸头孢吡肟药物制剂治疗中耳炎的新适应症 | |
CN100999487A (zh) | 磺化去氢枞酸亚铁盐、制备方法及其医药用途 | |
CN102342939B (zh) | 黄连素-苯乙酸类衍生物或其盐在制备治疗抗微生物药物中的应用 | |
CN102633815A (zh) | 头孢西丁酯化前体药物化合物及其口服制剂 | |
CN103193797A (zh) | 7-tmca盐酸盐的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: HANGZHOU ADAMERCK PHARMLABS INC. Free format text: FORMER OWNER: ZHEJIANG ADAMERCK PHARMLABS INC. Effective date: 20100426 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20100426 Address after: 7, 310011, 39 Cheung Xiang Road, Zhejiang, Hangzhou Applicant after: Hangzhou Aomo Medical Technology Co., Ltd. Address before: 7, 310011, 39 Cheung Xiang Road, Zhejiang, Hangzhou Applicant before: Hangzhou Adamerck Medicine Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: HANGZHOU AOMO PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: HANGZHOU AOMO MEDICAL TECHNOLOGY CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 5 Building 7, building 39, 310011 Cheung Road, Hangzhou, Zhejiang, Gongshu District Patentee after: HANGZHOU ADAMERCK PHARMLABS INC. Address before: 7, 310011, 39 Cheung Xiang Road, Zhejiang, Hangzhou Patentee before: Hangzhou Aomo Medical Technology Co., Ltd. |